(Q40529135)

English

Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment

scientific article published on 23 September 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment (English)

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Evanthia Galanis

10

object named as

Evanthia Galanis

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

author name string

Jayson Hardcastle

1

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Lisa Mills

2

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Courtney S Malo

3

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Fang Jin

4

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Cheyne Kurokawa

5

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Hirosha Geekiyanage

6

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Mark Schroeder

7

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Jann Sarkaria

8

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Aaron J Johnson

9

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

publication date

1 April 2017

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

19

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

4

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

493-502

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

PD-L1 expression and prognostic impact in glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Emerging therapies for glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Medical management of high-grade astrocytoma: current and emerging therapies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Oncolytic viruses as therapeutic cancer vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

HMGB1 in cancer: good, bad, or both?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Origin and differentiation of microglia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Measles virus causes immunogenic cell death in human melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Adherens junction protein nectin-4 is the epithelial receptor for measles virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Immunological factors relating to the antitumor effect of temozolomide chemoimmunotherapy in a murine glioma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

HMGB1 mediates endogenous TLR2 activation and brain tumor regression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

CD46 represents a target for adenoviral gene therapy of malignant glioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)/ADAM-17.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Restriction of measles virus RNA synthesis by a mouse host cell line: trans-complementation by polymerase components or a human cellular factor(s)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

SLAM (CDw150) is a cellular receptor for measles virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

Cytotoxic cells in immunodeficient athymic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

15 June 2018

MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

17 June 2018

Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

17 June 2018

CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

17 June 2018

Glioma virus therapies between bench and bedside

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

17 June 2018

A comparative review of cell culture systems for the study of microglial biology in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

17 June 2018

Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

17 June 2018

CD46 expression does not overcome the intracellular block of measles virus replication in transgenic rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

17 June 2018

Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

20 August 2018

Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

20 August 2018

Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

20 August 2018

Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5464320

20 August 2018

In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/27663389

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/NEUONC/NOW179

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 May 2018

http://europepmc.org/abstract/PMC/5464320

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40529135&oldid=1900011865"